all report title image
  • Published On : Feb 2022
  • Code : CMI4947
  • Industry : Pharmaceutical
  • Pages : 204
  • Formats :

Bovine mastitis is a medical condition that is common in dairy cows. It refers to the inflammation of mammary gland and udder tissue. The disease can cause harm to the milk-secreting tissues in cows, which is one of the main reasons, it is considered as a dangerous condition. The increased global incidence of bovine mastitis is expected to have a positive impact on the overall market growth over the forecast period. When mastitis is discovered, the first aid is to apply ice cubes to the udder surface. Infected milk from diseased teats should be drained three times a day and disposed properly. To ensure hygienic disposal, a 5% phenol solution can be added to the infected milk.

Global bovine mastitis market is estimated to be valued at US$ 1,423.5 Million in 2022 and is expected to reach US$ 2,134.3 Million by 2030, at a CAGR of 5.2% during the forecast period (2022-2030).

Figure 1. Global Bovine Mastitis Market Share (%), By Region, 2022

Bovine Mastitis  | Coherent Market Insights

Rising incidence of bovine mastitis is expected to drive the market growth over the forecast period.

The increasing incidence of bovine mastitis is expected to drive the market growth over the forecast period For instance, the global incidence of bovine mastitis ranges between 0 and 200 cows, according to the Cornell University College of Veterinary Medicine. Furthermore, the University of Glasgow estimates that bovine mastitis will cost between US$19.7 billion and $ 30 billion in annual healthcare costs, globally. Moreover, rising prevalence of bovine mastitis infections during the dry season, as well as the increased benefits of non-antibiotic intramammary products such as Teat Sealants in preventing new intramammary infections during the dry season, are expected to drive the market growth.

CMI table icon

Bovine Mastitis Market Report Coverage

Report Coverage Details
Base Year: 2021 Market Size in 2022: US$ 1,423.5 Mn
Historical Data for: 2017 to 2020 Forecast Period: 2022 to 2030
Forecast Period 2022 to 2030 CAGR: 5.2% 2030 Value Projection: US$ 2,134.3 Mn
Geographies covered:
  • North America: U.S. and Canada
  • Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
  • Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
  • Middle East: GCC Countries, Israel, and Rest of Middle East
  • Africa: South Africa, North Africa, and Central Africa
Segments covered:
  • By Type: Clinical Mastitis, Sub-clinical Mastitis
  • By Product: Antibiotics, Vaccines, Pain Killers, Others
  • By Route of Administration: Intra-mammary, Systemic
  • By Therapy: Lactating Period, Dry Period (Antibiotics, Teat Sealants)
  • By End User: Veterinary Centers, Hospital, Clinics, Others
Companies covered:

Zoetis, Merck & Co., Inc., Boehringer Ingelheim International GmbH, Bayer AG, Elanco, Ceva, West Way Health, Norbrook, DeLaval, ImmuCell Corporation, Advanced Animal Diagnostics, and Nimrod Veterinary Products Ltd.

Growth Drivers:
  • Increasing incidence of bovine mastitis
  • Increasing product launches
  • Technological advances in the field of drug discovery and development for the treatment of bovine mastitis
Restraints & Challenges:
  • Increased antibiotic resistance
  • Lack of awareness about the disease

Figure 2. Global Bovine Mastitis Market Share (%), By Therapy, 2022

Bovine Mastitis  | Coherent Market Insights

Increasing product launches for animal healthcare is expected to boost the market growth during the forecast period.

Cows are more susceptible to mastitis during dry off due to the environmental and physiological changes they go through. Because keratin plug growth changes throughout the dry period, a cow's natural barrier against new intramammary infections, pathogen risk is higher. When dry cows are exposed to high levels of environmental infections, National Mastitis Council's Recommended Mastitis Control Program recommends using a teat sealant. For instance, in February 2020 Merck & Co. Inc. announced the launch of Shut Out, a sterile, antibiotic-free barrier and a novel teat sealant solution. The product is intended to be used prior to dry off, in order to help avoid intramammary infections.

Global Bovine Mastitis Market– Impact of Coronavirus (COVID-19) Pandemic

Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 100 countries across the globe and the World Health Organization declared it as a public health emergency in 2020. According to the Coronavirus Disease (COVID-19) Weekly Epidemiological Update by the World Health Organization, the number of COVID-19 cases reported globally as of August 2, 2021 are approximately 198,234,951 confirmed cases with around 4,227,359 deaths. The coronavirus or COVID-19 outbreak started from Wuhan, China and has spread across continents, affecting various industries globally.

Even during the epidemic, despite lockdown and social distancing procedures, the persistent demand for dairy products has surfaced in favor of the market growth. Moreover, as these products fall under the category of essential services, the market is estimated to grow rapidly during the forecast period.

Global Bovine Mastitis Market: Restraint

The increasing antibiotic resistance and lack of awareness about the bovine mestitis disease are the major factors that are expected to hinder growth of the global bovine mastitis market.

Key Players

Major players operating in the global bovine mastitis market include Zoetis, Merck & Co., Inc., Boehringer Ingelheim International GmbH, Bayer AG, Elanco, Ceva, West Way Health, Norbrook, DeLaval, ImmuCell Corporation, Advanced Animal Diagnostics, and Nimrod Veterinary Products Ltd.

Bovine mastitis is characterized by a prolonged and inflammatory response of the udder tissue, as a result of either physical trauma or microorganism-caused illnesses. It is a life threatening mammary gland infection that is most prevalent in dairy cows globally. It's a condition known for causing damage on the dairy industry's profit margin. Mastitis is caused by a huge number of different microorganism species. Viruses, mycoplasmas, fungi, and bacteria are among them. Mastitis manifests itself as a red, hardened lump in the udder. The enlarged mammary gland is extremely hot, and even touching it causes pain and discomfort in animals. To avoid milking, animals will not touch or kick the udder. Blood clots, foul-smelling brown discharge, and milk clots are common in this condition.

Milk production comes to a halt or is seriously hampered as the animal's internal temperature rises. Lack of appetite, mobility issues due to a bloated udder, and soreness are some of the other symptoms of bovine mestitis. Sunken eyes, intestinal problems, and diarrhoea are all symptoms among dairy animals suffering from bovine mestitis. California Mastitis Test (CMT) can diagnose mastitis at an early stage (sub-clinical) before symptoms occur. It is a simple test that may be done on little amount of milk. Early identification aids in preventing the disease from progressing to clinical stages, which would result in significant losses for dairy farmers.

Market Dynamics

One of the primary factors driving the global bovine mastitis market expansion include increasing prevalence of bovine mastitis across the world. For instance, according to an article published by the US National Library of Medicine and National Institutes of Health in August 2020, at the quarter, cow, and farm level, the overall prevalence of clinical and subclinical mastitis was 51.6% (815/1,580), 74.4% (294/395), and 76.6% (118/154), respectively.

Key features of the study:

  • This report provides in-depth analysis of the global bovine mastitis market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022-2030), considering 2021 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global bovine mastitis market based on the following parameters – company highlights, types portfolio, key highlights, financial performance, and market strategies.
  • Key companies covered as a part of this study include Zoetis, Merck & Co., Inc., Boehringer Ingelheim International GmbH, Bayer AG, Elanco, Ceva, West Way Health, Norbrook, DeLaval, ImmuCell Corporation, Advanced Animal Diagnostics, and Nimrod Veterinary Products Ltd.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global bovine mastitis market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global bovine mastitis market

Detailed Segmentation:

  • Global Bovine Mastitis Market, By Type:
    • Clinical Mastitis
    • Sub-clinical Mastitis
  • Global Bovine Mastitis Market, By Product:
    • Antibiotics
    • Vaccines
    • Pain Killers
    • Others
  • Global Bovine Mastitis Market, By Route of Administration:
    • Intra-mammary
    • Systemic
  • Global Bovine Mastitis Market, By Therapy:
    • Lactating Period
    • Dry Period
      • Antibiotics
      • Teat Sealants
  • Global Bovine Mastitis Market, By End User:
    • Veterinary Centers
    • Hospital
    • Clinics
    • Others
  • Global Bovine Mastitis Market, By Region:       
    • North America
      • By Country
        • U.S.
        • Canada
    • Latin America
      • By Country
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Country
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Country
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Country
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Country/Region
        • South Africa
        • Central Africa
        • North Africa
  • Company Profiles
    • Zoetis
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Merck & Co., Inc.
    • Boehringer Ingelheim International GmbH
    • Bayer AG
    • Elanco
    • Ceva
    • West Way Health
    • Norbrook
    • DeLaval
    • ImmuCell Corporation
    • Advanced Animal Diagnostics
    • Nimrod Veterinary Products Ltd

 “*” marked represents similar segmentation in other categories in the respective section.

Frequently Asked Questions

The global bovine mastitis market size is estimated to be valued at US$ 1,423.5 Million in 2022 and is expected to exhibit a CAGR of 5.2% between 2022 and 2030.
The increasing incidence of bovine mastitis, increasing product launches, and technological advances in the field of drug discovery and development for the treatment of clinical mastitis are the major factors that are expected to drive growth of the market.
Antibiotics segment is the leading product segment in the market.
Increased antibiotic resistance and lack of awareness about the disease are the major factors restraining growth of the market.
Major players operating in the market include Zoetis, Merck & Co., Inc., Boehringer Ingelheim International GmbH, Bayer AG, Elanco, Ceva, West Way Health, Norbrook, DeLaval, ImmuCell Corporation, Advanced Animal Diagnostics, and Nimrod Veterinary Products Ltd.

Related Reports

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo